Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

HBI 2020: Hospital sector is moving to outcome-based payment – insurers may get left behind

The for-profit hospital sector is moving slowly but inexorably towards value and outcome-linked reimbursement and the role for insurers within that, if there is one, is far from clear. That was the message from HBI 2020's 'Hospitals: The balance of power with payors' session where the CEOs of Mediclinic International and Steward Health Care discussed the topic with an ex-UnitedHealth Group executive.
December 17, 2020

At $2.4bn, Rede D’Or IPO would be emerging market hospital record

Brazil's largest private hospital chain Rede D'Or's December 10 IPO could raise US$2.4bn, which would make it the largest emerging market hospital listing ever and second overall. That is despite the fact 2020 revenue is flat and net profit is down 80% due to COVID-19.
November 26, 2020

Emerging market lab roundup

HBI rounds up the latest news from the world's largest emerging market laboratories, including Grupo Fleury in Brazil striking a deal with a rival, and lab activity normalising in India.
November 19, 2020

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 
November 18, 2020

CVC “frontrunner to buy Eugin”

HBI hears that CVC is frontrunner to buy international IVF chain Eugin as parent company NMC Health's administrators Alvarez and Marsal looks to complete a lender-led sale of the group by Spring 2021.
November 12, 2020

Integrated model ‘alive and kicking’ despite Banmedica closures

Greater scrutiny is being brought to bear on the use of integrated models in Chile - a practice where any impropriety is sidestepped through the use of holding companies. Where does this leave the likes of UnitedHealth Group-owned Banmedica, which has just closed four health centres in its Vidaintegra network - and why is public concern mounting about private insurers profits?
October 30, 2020

Veritas Intercontinental raises €5m as it off-shoots from ailing US business

Veritas Intercontinental, the spin-off of US genome sequencing group, Veritas Genetics, has raised €5m from existing investors to help finish building a new lab in Spain. CEO Javier de Echevarría tells HBI that the money will help to establish its independence from its former parent company which temporarily ceased US trading last year. 
October 15, 2020

Hapvida and Intermedica continue M&A binge through crisis

Brazilian listed HMOs (health management organisations) Hapvida Saude and Grupo Notre Dame Intermedica have resumed their M&A binge since July after a quiet second quarter, despite the pandemic continuing to rage throughout the country. 
September 29, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us